Skip to main content

Prognostic value of Cardiopulmonary Exercise Testing in Heart Failure with preserved Ejection Fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) Project

Published: 25 January 2016

The American Heart Journal published a new article on the prognostic value of Cardio Pulmonary Exercise Test (CPX) in heart failure (HF) patients.

Although cardiopulmonary exercise testing in patients with heart failure and reduced ejection fraction (HFrEF) is well established, there is limited data on the value of CPX variables in patients with HF and preserved EF (HFpEF). The study sought to determine the prognostic value of select CPX measures in patients with HFpEF.

The study findings support the prognostic utility of peak VO2 and ppMVO2 in patients with HFpEF. The study can be purchased at the following link: click here

Get in touch

COSMED strives to provide the best service possible with every contact!

Fill the online forms to get the info you're looking for right now!

Register your Product

Register your Product

Fill the online form to get software upgrades and more advantages

Read more

Request for information

Request for information

Fill the online form to get more information or a quote 

Read more

Request for Support

Request for Support

Fill the online form in order to help us fully understand your problem

Read more

COSMED LOGO
COSMED LOGO

COSMED is a world leading supplier of Cardio Pulmonary, Metabolic and Body Composition testing solutions to Sports Science, Medicine, Professional Sport and Wellness.

COSMED is a world leading supplier of Cardio Pulmonary, Metabolic and Body Composition testing solutions to Sports Science, Medicine, Professional Sport and Wellness.

FOLLOW US ON

FOLLOW US ON